TickerFacts.

Bio-Techne Corp (TECH): Share Repurchases

Annual figures by period end, from SEC filings.

$41.67M
Year ended 2026-06-30
+28.7%
3-year compound annual growth
-0.7%
5-year compound annual growth
$275.73M2009-06-30: $90.63M2010-06-30: $14.97M2011-06-30: $1.94M2012-06-30: $23.60M2013-06-30: $1.82M2014-06-30: $02015-06-30: $02018-06-30: $02019-06-30: $15.40M2020-06-30: $50.11M2021-06-30: $43.18M2022-06-30: $160.95M2023-06-30: $19.56M2024-06-30: $80.04M2025-06-30: $275.73M2026-06-30: $41.67M$41.67M
2009-06-30 Share Repurchases (USD) 2026-06-30
Period endedShare RepurchasesChange YoYSource filing
2026-06-30$41.67M-84.9%2026-08-24, From 2025-07-01
2025-06-30$275.73M+244.5%2026-08-24, From 2024-07-01
2024-06-30$80.04M+309.2%2026-08-24, From 2023-07-01
2023-06-30$19.56M-87.8%2025-08-22, From 2022-07-01
2022-06-30$160.95M+272.8%2024-08-22, From 2021-07-01
2021-06-30$43.18M-13.8%2023-08-23, From 2020-07-01
2020-06-30$50.11M+225.3%2022-08-24, From 2019-07-01
2019-06-30$15.40Mn/a2021-08-25, From 2018-07-01
2018-06-30$0n/a2020-08-26, From 2017-07-01
No annual figure between 2015-06-30 and 2018-06-30.
2015-06-30$0n/a2015-08-31, From 2014-07-01
2014-06-30$0-100.0%2015-08-31, From 2013-07-01
2013-06-30$1.82M-92.3%2015-08-31, From 2012-07-01
2012-06-30$23.60Mn/m2014-08-29, From 2011-07-01
2011-06-30$1.94M-87.0%2013-08-29, From 2010-07-01
2010-06-30$14.97M-83.5%2012-08-29, From 2009-07-01
2009-06-30$90.63Mn/a2011-08-29, From 2008-07-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Bio-Techne Corp (TECH)2026-06-30$41.67M-84.9%
Halozyme Therapeutics, Inc. (HALO)2025-12-31$342.37M+36.9%
Moderna, Inc. (MRNA)2025-12-31$2.00Mn/a
Repligen Corp (RGEN)2025-12-31$0n/a
Qiagen N.V. (QGEN)2025-12-31$280.09M-4.1%
Exelixis, Inc. (EXEL)2026-01-02$947.51M+45.3%
Neurocrine Biosciences Inc (NBIX)2025-12-31$167.70M-44.1%
ADMA Biologics, Inc. (ADMA)2025-12-31$31.94Mn/a
Champions Oncology, Inc. (CSBR)2025-04-30$0-100.0%

Compare TECH, HALO, MRNA, RGEN side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗